Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial - Cortes, J. E., Kim, D.-W., Pinilla-Ibarz, J., le Coutre, P. D., Paquette, R., Chuah, C., Nicolini, F. E., Apperley, J. F., Khoury, H. J., Talpaz, M., De; Angelo, D. J., Abruzzese, E., Rea, D., Baccarani, M., Müller, M. C., Gambacorti-Passerini, C., Lustgarten, S., Rivera, V. M., Haluska, F. G., Guilhot, F., Deininger, M. W., Hochhaus, A., Hughes, T. P., Shah, N. P., Kantarjian, H. M. (American Society of Hematology (ASH), 2018)
6309836
Keywords: W; WW-YZ